134 related articles for article (PubMed ID: 22349638)
1. Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells.
Ikeda J; Mamat S; Tian T; Wang Y; Luo W; Rahadiani N; Aozasa K; Morii E
Lab Invest; 2012 Apr; 92(4):606-14. PubMed ID: 22349638
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.
Yasuda K; Torigoe T; Morita R; Kuroda T; Takahashi A; Matsuzaki J; Kochin V; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
PLoS One; 2013; 8(8):e68187. PubMed ID: 23967051
[TBL] [Abstract][Full Text] [Related]
3. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of tumor cells in terms of cancer-initiating cells.
Morii E
J Toxicol Pathol; 2017 Jan; 30(1):1-6. PubMed ID: 28190919
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte Antigen Class 1.
Shirosaki T; Kawai N; Ebihara Y; Murai A; Kubo T; Morita R; Murata K; Kanaseki T; Tsukahara T; Shichinohe T; Hirohashi Y; Hirano S; Torigoe T
Anticancer Res; 2024 May; 44(5):1877-1883. PubMed ID: 38677758
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
[TBL] [Abstract][Full Text] [Related]
8. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines.
Ikeda J; Mamat S; Tian T; Wang Y; Rahadiani N; Aozasa K; Morii E
Am J Pathol; 2010 Dec; 177(6):3081-8. PubMed ID: 20952592
[TBL] [Abstract][Full Text] [Related]
10. p53 functional states are associated with distinct aldehyde dehydrogenase transcriptomic signatures.
Gui S; Xie X; O'Neill WQ; Chatfield-Reed K; Yu JG; Teknos TN; Pan Q
Sci Rep; 2020 Jan; 10(1):1097. PubMed ID: 31974410
[TBL] [Abstract][Full Text] [Related]
11. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
12. ROS activated prodrug for ALDH overexpressed cancer stem cells.
Won M; Kim JH; Ji MS; Kim JS
Chem Commun (Camb); 2021 Dec; 58(1):72-75. PubMed ID: 34874378
[TBL] [Abstract][Full Text] [Related]
13. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
Wang L; Park P; Zhang H; La Marca F; Lin CY
Int J Cancer; 2011 Jan; 128(2):294-303. PubMed ID: 20309879
[TBL] [Abstract][Full Text] [Related]
14. The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation.
Raha D; Wilson TR; Peng J; Peterson D; Yue P; Evangelista M; Wilson C; Merchant M; Settleman J
Cancer Res; 2014 Jul; 74(13):3579-90. PubMed ID: 24812274
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
16. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance.
Sydow K; Daiber A; Oelze M; Chen Z; August M; Wendt M; Ullrich V; Mülsch A; Schulz E; Keaney JF; Stamler JS; Münzel T
J Clin Invest; 2004 Feb; 113(3):482-9. PubMed ID: 14755345
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
[TBL] [Abstract][Full Text] [Related]
18. Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.
Bogen A; Buske C; Hiddemann W; Bohlander SK; Christ O
Exp Hematol; 2017 Mar; 47():54-63. PubMed ID: 27826122
[TBL] [Abstract][Full Text] [Related]
19. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase.
Clay MR; Tabor M; Owen JH; Carey TE; Bradford CR; Wolf GT; Wicha MS; Prince ME
Head Neck; 2010 Sep; 32(9):1195-201. PubMed ID: 20073073
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.
Rasheed ZA; Yang J; Wang Q; Kowalski J; Freed I; Murter C; Hong SM; Koorstra JB; Rajeshkumar NV; He X; Goggins M; Iacobuzio-Donahue C; Berman DM; Laheru D; Jimeno A; Hidalgo M; Maitra A; Matsui W
J Natl Cancer Inst; 2010 Mar; 102(5):340-51. PubMed ID: 20164446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
